SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biofield may double within 3 months!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Haolin Ni who wrote (49)1/11/1997 5:01:00 AM
From: Mike Winn   of 120
 
Haolin,

I don't know if BZET will slip back to 10 or not. Last year, it was
very stable at around 15 for a long time until the stock market crashed
in July, in particular biotech stocks. BZET is supposed to ship
it scanners to Europe and Japan very soon. The FDA approval in the
US may take anywhere from 6 months to 12 months. Lately, the FDA has
been very stringent with co. making electronics devices, especially
the devices that have software. The FDA requires validation tests
similar to the FAA for flight control boxes. Depending how well
Biofield documents its software, the approval process may be fast
or slow. In the mean time, the stock may move up on the news of the
sale to Europe. The approval may come quicker if the scanner really
works in Europe and doctors in this country may press for quicker
approval.

Anyway, I got out of BZET because I know of a few other stocks
that will give me the same or better return as BZET, and those co. have
revenue.

I really don't know where BZET will head to in the next few months.

Mike.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News